NanoEntek Receives Approval for COVID-19 Antibody Test Kit Use in Brazil
[Asia Economy Reporter Jang Hyowon] NanoEntek (CEO Jeong Chan-il) announced on the 11th that it has received approval for use from the Brazilian Health Regulatory Agency (ANVISA) for its COVID-19 antibody diagnostic kit (FREND COVID-19 IgG/IgM Duo).
In the clinical evaluation by the Brazilian National Institute of Quality Control in Health (INCQS), the kit achieved a sensitivity of 96.4% and a specificity of 97.1%.
Hot Picks Today
"How Much Will They Get?" 600 Million vs. 460 Million vs. 160 Million... Samsung Electronics DS Division's 'Three Wallets Under One Roof'
- Opening a Bank Account in Korea Is Too Difficult..."Over 150,000 Won in Notarization Fees Just for a Child's Account and Debit Card" [Foreigner K-Finance Status]②
- [Report] "Maybe Kim Bugyeom This Time" "Still Choo Kyungho"... Will the Tables Turn?
- Room Prices Soar from 60,000 to 760,000 Won and Sudden Cancellations: "We Won't Even Buy Water in Busan" — BTS Fans Outraged
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
Brazil, with approximately 4.19 million confirmed COVID-19 cases, is one of the countries most affected by COVID-19 after the United States and India, where cases have recently surged. Additionally, due to high poverty rates, population density, and many areas with poor healthcare systems, there is a high demand for antibody kits that provide rapid and accurate diagnosis on site.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
!["Please Help Us": How Much Do Those Bowing Deeply for Your Vote Really Earn? [Data Pick]](https://cwcontent.asiae.co.kr/asiaresize/307/2026052010120870131_1779239528.png)
